Product News
Seer To Feature Proteomic Advancements in Cancer and RNA Therapy Research Among Other Findings at US HUPO 2025
Seer, Inc. (Nasdaq: SEER), announced that the company will showcase new findings at the 21st Annual US Human Proteome Organization (HUPO) Conference in Philadelphia, PA, from February 22-26, 2025.
Product News
Dovetail Genomics Announces Early Access Service for FFPE Sample Analysis, Enhancing Cancer Research Capabilities
Dovetail Genomics, announces the availability of its early access services for FFPE (Formalin-Fixed Paraffin-Embedded) sample analysis, offering new capabilities for detecting structural variants and profiling RNA in oncology research.
Product News
Landmark Study at Homerton University Hospital Confirms GastroPanel®’s Diagnostic Accuracy
BIOHIT HealthCare is pleased to announce that a clinical study conducted by Homerton University Hospital NHS Foundation Trust, London, has confirmed the diagnostic accuracy of GastroPanel in identifying gastric cancer risk in patients.
Product News
Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement With LINDIS Biotech for the Commercial Supply of Catumaxomab
Celonic Group, a “Pure Play” biologics contract development and manufacturing organization (CDMO), announced the signing of a multi-year commercial manufacturing agreement with LINDIS Biotech.
Product News
Defined Hydrogel Enables Reproducible Culture of Cancer Cells in Xenograft Models
AMSBIO has launched MatriMix for PDX, a fully defined extracellular matrix (ECM) hydrogel comprising of collagen, laminin-511 E8 fragments and hyaluronic acid optimized to support patient-derived xenograft (PDX) studies.
Product News
Geneoscopy Closes $105M in Series C Funding Round To Power Next-Generation of Gastrointestinal Diagnostic Tests
Bio-Rad leads investment to support the launch of ColoSense®, a non-invasive colorectal cancer screening test, and advance diagnostic innovations for inflammatory bowel disease.
Advertisement
